PL370656A1 - Płynna kompozycja polipeptydów modyfikowanego czynnika VII - Google Patents
Płynna kompozycja polipeptydów modyfikowanego czynnika VIIInfo
- Publication number
- PL370656A1 PL370656A1 PL02370656A PL37065602A PL370656A1 PL 370656 A1 PL370656 A1 PL 370656A1 PL 02370656 A PL02370656 A PL 02370656A PL 37065602 A PL37065602 A PL 37065602A PL 370656 A1 PL370656 A1 PL 370656A1
- Authority
- PL
- Poland
- Prior art keywords
- liquid composition
- factor vii
- modified factor
- vii polypeptides
- polypeptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200101949 | 2001-12-21 | ||
DKPA200101948 | 2001-12-21 | ||
US34639902P | 2002-01-07 | 2002-01-07 | |
US34688802P | 2002-01-07 | 2002-01-07 | |
PCT/DK2002/000894 WO2003055511A1 (en) | 2001-12-21 | 2002-12-20 | Liquid composition of modified factor vii polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
PL370656A1 true PL370656A1 (pl) | 2005-05-30 |
Family
ID=27439852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL02370656A PL370656A1 (pl) | 2001-12-21 | 2002-12-20 | Płynna kompozycja polipeptydów modyfikowanego czynnika VII |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040043933A1 (pl) |
EP (1) | EP1458407A1 (pl) |
JP (1) | JP2005530682A (pl) |
CN (1) | CN1606452A (pl) |
AU (1) | AU2002351755A1 (pl) |
BR (1) | BR0215218A (pl) |
CA (1) | CA2470313A1 (pl) |
HU (1) | HUP0402303A2 (pl) |
IL (1) | IL162618A0 (pl) |
PL (1) | PL370656A1 (pl) |
RU (1) | RU2004122430A (pl) |
WO (1) | WO2003055511A1 (pl) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2003134701A (ru) * | 2001-05-02 | 2005-03-27 | Ново Нордиск А/С (DK) | Модифицированный fvii при лечении ards |
BR0215216A (pt) | 2001-12-21 | 2004-11-16 | Novo Nordisk Healthcare Ag | Composição aquosa lìquida, método para preparar uma composição aquosa lìquida de um polipeptìdeo de fator vii, uso de uma composição aquosa lìquida, e, método para o tratamento de uma sìndrome de resposta ao fator vii |
KR20040065278A (ko) * | 2001-12-21 | 2004-07-21 | 노보 노르디스크 에이/에스 | 변경된 인자 ⅶ 폴리펩티드의 액체 조성물 |
US20040009918A1 (en) * | 2002-05-03 | 2004-01-15 | Hanne Nedergaard | Stabilised solid compositions of modified factor VII |
KR101212025B1 (ko) | 2002-06-21 | 2013-01-09 | 노보 노르디스크 헬스 케어 악티엔게젤샤프트 | 인자 ⅶ 폴리펩티드의 안정화된 고체 조성물 |
CA2518327A1 (en) * | 2003-03-18 | 2004-09-30 | Novo Nordisk Health Care Ag | Liquid, aqueous, pharmaceutical compositions of factor vii polypeptides |
US7897734B2 (en) * | 2003-03-26 | 2011-03-01 | Novo Nordisk Healthcare Ag | Method for the production of proteins |
AU2004241698A1 (en) * | 2003-05-23 | 2004-12-02 | Novo Nordisk Health Care Ag | Protein stabilization in solution |
ES2382157T3 (es) | 2003-06-25 | 2012-06-05 | Novo Nordisk Health Care Ag | Composición líquida de polipépttidos del factor VII |
ATE446768T1 (de) * | 2003-07-01 | 2009-11-15 | Novo Nordisk Healthcare Ag | Flüssige wässrige pharmazeutische zusammnesetzung von factor vii polypeptiden |
EP1656158B1 (en) * | 2003-08-14 | 2016-03-09 | Novo Nordisk Health Care AG | Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
WO2005023308A1 (en) * | 2003-09-05 | 2005-03-17 | Maxygen Holdings Ltd. | Formulations of vitamin k-dependent polypeptides and sulfoalkyl ether cycloextrins |
MXPA06006886A (es) * | 2003-12-19 | 2006-09-04 | Novo Nordisk Healthcare Ag | Composiciones estabilizadas de polipeptidos del factor vii. |
HUE042304T2 (hu) | 2004-04-23 | 2019-06-28 | Cydex Pharmaceuticals Inc | DPI készítmény, amely szulfoalkil-éter-ciklodextrint tartalmaz |
RU2006138181A (ru) | 2004-05-04 | 2008-06-10 | Ново Нордиск Хелс Кеа Аг (Ch) | О-связанные гликоформы полипептидов и способ их изготовления |
US7148067B2 (en) * | 2004-08-31 | 2006-12-12 | The Board Of Trustees Of The University Of Illinois | Thromboplastin reagents |
JP2006137678A (ja) * | 2004-11-10 | 2006-06-01 | Shionogi & Co Ltd | インターロイキン−2組成物 |
EP1853926A2 (en) * | 2005-02-16 | 2007-11-14 | The Board Of Trustees Of The University Of Illinois | Procoagulants based on metal-chelating lipids |
ATE505488T1 (de) * | 2005-03-04 | 2011-04-15 | Univ Illinois | Modulator von coagulationskaskaden und fibrinolytischen kaskaden |
US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
SI2147096T1 (sl) * | 2007-04-13 | 2015-07-31 | Catalyst Biosciences, Inc., | Modificirani polipeptidi faktorja VII in njihove uporabe |
US8821861B2 (en) * | 2007-10-05 | 2014-09-02 | The Board Of Trustees Of The University Of Illinois | Fibrin sealant |
US20100297257A1 (en) * | 2007-11-09 | 2010-11-25 | National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) | Anticoagulant antagonist and hemophillia procoagulant |
TWI538916B (zh) | 2008-04-11 | 2016-06-21 | 介控生化科技公司 | 經修飾的因子vii多肽和其用途 |
KR20210145307A (ko) * | 2008-08-15 | 2021-12-01 | 아이언우드 파마슈티컬스, 인코포레이티드 | 경구 투여를 위한 리나클로타이드-함유 제형 |
JP2013501071A (ja) * | 2009-08-06 | 2013-01-10 | アイロンウッド ファーマシューティカルズ, インコーポレイテッド | リナクロチドを含む処方物 |
MX340234B (es) | 2010-02-17 | 2016-07-01 | Ironwood Pharmaceuticals Inc | Tratamiento para transtornos gastrointestinales. |
EP3626253B8 (en) | 2010-08-11 | 2022-04-20 | Ironwood Pharmaceuticals, Inc. | Stable formulations of linaclotide |
MX347354B (es) | 2011-08-17 | 2017-04-24 | Ironwood Pharmaceuticals Inc | Tratamientos para trastornos gastrointestinales. |
ES2694328T3 (es) | 2013-03-12 | 2018-12-19 | Sumitomo Dainippon Pharma Co., Ltd. | Composición acuosa líquida |
CN107490676B (zh) * | 2017-08-10 | 2019-02-12 | 迈克生物股份有限公司 | 一种补体c3检测试剂盒及检测方法 |
CN107490675B (zh) * | 2017-08-10 | 2019-02-12 | 迈克生物股份有限公司 | 一种免疫比浊试剂盒及检测方法 |
CN107356764A (zh) * | 2017-08-10 | 2017-11-17 | 迈克生物股份有限公司 | 一种载脂蛋白e检测试剂盒及检测方法 |
CN107490696A (zh) * | 2017-08-10 | 2017-12-19 | 迈克生物股份有限公司 | 一种视黄醇结合蛋白检测试剂盒及检测方法 |
WO2021030787A1 (en) | 2019-08-15 | 2021-02-18 | Catalyst Biosciences, Inc. | Modified factor vii polypeptides for subcutaneous administration and on-demand treatment |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2916711A1 (de) * | 1979-04-25 | 1980-11-06 | Behringwerke Ag | Blutgerinnungsfaktoren und verfahren zu ihrer herstellung |
US5833982A (en) * | 1991-02-28 | 1998-11-10 | Zymogenetics, Inc. | Modified factor VII |
SE9301581D0 (sv) * | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Protein formulation |
US5925738A (en) * | 1995-12-01 | 1999-07-20 | The American National Red Cross | Methods of production and use of liquid formulations of plasma proteins |
US5770700A (en) * | 1996-01-25 | 1998-06-23 | Genetics Institute, Inc. | Liquid factor IX formulations |
US20010031721A1 (en) * | 1999-05-05 | 2001-10-18 | Chandra Webb | Highly concentrated, lyophilized, and liquid factor IX formulations |
-
2002
- 2002-12-20 PL PL02370656A patent/PL370656A1/pl unknown
- 2002-12-20 EP EP02787469A patent/EP1458407A1/en not_active Withdrawn
- 2002-12-20 RU RU2004122430/13A patent/RU2004122430A/ru not_active Application Discontinuation
- 2002-12-20 IL IL16261802A patent/IL162618A0/xx unknown
- 2002-12-20 AU AU2002351755A patent/AU2002351755A1/en not_active Abandoned
- 2002-12-20 JP JP2003556087A patent/JP2005530682A/ja not_active Withdrawn
- 2002-12-20 CN CNA028256433A patent/CN1606452A/zh active Pending
- 2002-12-20 CA CA002470313A patent/CA2470313A1/en not_active Abandoned
- 2002-12-20 WO PCT/DK2002/000894 patent/WO2003055511A1/en active Application Filing
- 2002-12-20 HU HU0402303A patent/HUP0402303A2/hu unknown
- 2002-12-20 BR BR0215218-5A patent/BR0215218A/pt not_active Application Discontinuation
-
2003
- 2003-06-23 US US10/602,340 patent/US20040043933A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1606452A (zh) | 2005-04-13 |
US20040043933A1 (en) | 2004-03-04 |
AU2002351755A1 (en) | 2003-07-15 |
WO2003055511A1 (en) | 2003-07-10 |
HUP0402303A2 (hu) | 2005-01-28 |
EP1458407A1 (en) | 2004-09-22 |
CA2470313A1 (en) | 2003-07-10 |
RU2004122430A (ru) | 2005-04-20 |
IL162618A0 (en) | 2005-11-20 |
JP2005530682A (ja) | 2005-10-13 |
BR0215218A (pt) | 2004-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402315A3 (en) | Liquid composition of factor vii polypeptides | |
IL162618A0 (en) | Liquid composition of modified factor vii polypeptides | |
EG24078A (en) | Liquid pharmaceutical composition | |
HUP0401116A3 (en) | Stable liquid peticide compositions | |
IL158802A0 (en) | Stable liquid formulations of antibodies | |
IL165608A0 (en) | Stabilised solid compositions of factor VII polypeptides | |
GB0119935D0 (en) | Perfume containing composition | |
GB0116825D0 (en) | Determination of material parameters | |
GB0117879D0 (en) | Storage of liquid compositions | |
AU2002358308A8 (en) | Fluid mixture composition sensor | |
HUP0400976A3 (en) | Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides | |
HK1063483A1 (en) | Liquid detergent composition | |
AU2002255354A1 (en) | Minoxidil-containing liquid composition | |
HUP0401985A3 (en) | Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides | |
EP1365818A4 (en) | COMPOSITION OF A POROUS ELEMENT FOR A BIOLOGICAL MATERIAL | |
EP1360964A4 (en) | USE OF A GALANINE-LIKE PEPTID | |
HRP20030546A2 (en) | Pharmaceutical composition containing citalopram | |
TW506438U (en) | Improved structure of liquid container | |
TW522848U (en) | Cottonbud containing liquid | |
AU2002340781A1 (en) | Pharmaceutical composition comprising factor vii polypeptides and thrombomodulin polypeptides | |
AU2002311270A1 (en) | Liquid composition | |
TW569752U (en) | Improved structure of container | |
TW480984U (en) | Improved structure of seasoner container | |
TW540341U (en) | Structure improvement of container | |
GB0104649D0 (en) | Spraying of liquids |